Robert A. Hodgson,
Rosalia Bertorelli,
Geoffrey B. Varty,
Jean E. Lachowicz,
Angelo Forlani,
Silva Fredduzzi,
Mary E. Cohen-Williams,
Guy A. Higgins,
Francesco Impagnatiello,
Elisa Nicolussi,
Leonard E. Parra,
Carolyn Foster,
Ying Zhai,
Bernie R. Neustadt,
Andrew W. Stamford,
Eric M. Parker,
Angelo Reggiani,
John C. Hunter,
- Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression. Hodgson, R.A., Bertorelli, R., Varty, G.B., Lachowicz, J.E., Forlani, A., Fredduzzi, S., Cohen-Williams, M.E., Higgins, G.A., Impagnatiello, F., Nicolussi, E., Parra, L.E., Foster, C., Zhai, Y., Neustadt, B.R., Stamford, A.W., Parker, E.M., Reggiani, A., Hunter, J.C. J. Pharmacol. Exp. Ther. (2009)